Skip to Content


Welcome to the 2017 Season

Important Notice: Dawson Creek Golf Club cannot host the zone qualifier May 27 & 28 as the course is too wet. The 2017 Zone 8 North Zone Qualifier will now be held at the Lone Wolf Golf Course in Taylor, BC. Registration is now closed. Best wishes everyone! Here are the tee times:

Saturday, May 27th -


Phillip Clavier, Derek MacDonald, Percy Peterkin


Dennis Kesterke, Bruce Ballantyne, Larry Ziprick


Brad Arndt, Len Holland, Thomas Nel, Brad Supernault

9:24 AM

Mayson Grunewald, Ritch Hosker, Jared Wylie, Christopher MacKay

Keep checking the calendar site for tournament updates! Clubs are asked to please submit their upcoming dates as soon as possible to Wendy at


Lone Wolf Junior Program is on Mondays - May 22, 29, June 5 & 12. Contact

Lone Wolf Pro Shop to register - 250-789-3711




Journal help user username password remember me article tools print this article indexing metadata how to cite item supplementary files review policy email this article (login required) email the author (login required)                                       journal content search all authors title abstract index terms full text browse by issue by author by title information for authors home about about current early view archives society editorial board reviewers log in register announcements search contact submission home > volume 24, no 4 (2011) > viazis one-year infliximab administration for the treatment of chronic refractory pouchitis nikos viazis, marios giakoumis, theodoros koukouratos, efstathios saprikis, elias anastasopoulos, mousa al-odat, georgios kechagias, georgios zacharakis, konstantinos markoglou, paraskevi gouma, demetrios g. Karamanolis abstract aim. To determine the efficacy of infliximab in the treatment of chronic refractory pouchitis, following ileo-pouch anal anastomosis (ipaa) for ulcerative colitis (uc). Methods: seven patients (4 females, 3 males) with chronic refractory pouchitis were included in an open study. Pouchitis was diagnosed by clinical plus endoscopic and histological criteria. Three patients had also fistulae (pouch-bladder in 1 and perianal in 2). Extraintestinal manifestations were also present in 4 patients (erythema nodosum in 2, arthralgiae in 2). cheap generic viagra viagra online buy cheap viagra buy viagra online viagra for sale buy cheap viagra cheap viagra cheap viagra buy viagra buy cheap viagra All patients were refractory to antibiotics, while 5 patients were refractory to azathioprine as well. Crohn's disease was carefully excluded in all patients after re-evaluation of the history and examination of the small bowel with enteroclysis or small bowel capsule endoscopy. Patients received infliximab 5 mg/kg at 0, 2 and 6 weeks and thereafter every 2 months for 1 year. Clinical response was classified as complete, partial, and no response. Fistulae closure was classified as complete, partial, and no closure. The pouchitis disease activity index (pdai) was also used as an outcome measure. Results: clinically, all patients improved. After 1 year of follow-up, 5 out of the 7 patients had a complete clinical response, and 2 out of the 3 patients with a fistula had complete fistulae closure. At the end of the follow-up period the median pdai dropped from 11 (baseline) (range, 10-14) to 5 (range, 3-8). Extraintestinal manifestations were in complete remission at the end of the follow up period as well. Conclusions: our results indicate that infliximab may be recommended for the treatment of chronic refractory pouchitis complicated or not by fistulae following ipaa for uc. Full text: pdf html. To this content, please recommend the title to your librarian. If your institution is on this list, you should login via openathens. If it is not, please login via athens login via other institutional login options you can purchase online access to this article for a 24-hour peri.          
      viagra side effects in men